Finch Therapeutics Group Inc (FNCH)
2.28
-0.02
(-0.87%)
USD |
NASDAQ |
May 06, 15:49
Finch Therapeutics Group Net Income (Quarterly): -3.041M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.041M |
| September 30, 2023 | -2.416M |
| June 30, 2023 | -6.95M |
| March 31, 2023 | -63.94M |
| December 31, 2022 | -27.01M |
| September 30, 2022 | -40.37M |
| June 30, 2022 | -22.70M |
| March 31, 2022 | -24.57M |
| Date | Value |
|---|---|
| December 31, 2021 | -19.06M |
| September 30, 2021 | -9.955M |
| June 30, 2021 | -15.17M |
| March 31, 2021 | -13.98M |
| December 31, 2020 | -13.09M |
| September 30, 2020 | -10.09M |
| June 30, 2020 | -8.259M |
| March 31, 2020 | -7.901M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-63.94M
Minimum
Mar 2023
-2.416M
Maximum
Sep 2023
-18.03M
Average
-13.54M
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 45.80M |
| Vanda Pharmaceuticals Inc | -2.40M |
| Sage Therapeutics Inc | -108.48M |
| BioSig Technologies Inc | -6.049M |
| Palisade Bio Inc | -2.971M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.681M |
| EPS Diluted (Quarterly) | -1.89 |
| Enterprise Value | -21.43M |
| Earnings Yield | -2.09K% |
| Normalized Earnings Yield | -2154.61 |